| The cytokine handbook, two-volume set AW Thomson, MT Lotze Elsevier, 2003 | 867 | 2003 |
| Stat3 promotes metastatic progression of prostate cancer J Abdulghani, L Gu, A Dagvadorj, J Lutz, B Leiby, G Bonuccelli, ... The American journal of pathology 172 (6), 1717-1728, 2008 | 320 | 2008 |
| Signal transducer and activator of transcription-5 activation and breast cancer prognosis MT Nevalainen, J Xie, J Torhorst, L Bubendorf, P Haas, J Kononen, ... Journal of Clinical Oncology 22 (11), 2053-2060, 2004 | 269 | 2004 |
| Prolactin and prolactin receptors are expressed and functioning in human prostate. MT Nevalainen, EM Valve, PM Ingleton, M Nurmi, PM Martikainen, ... The Journal of clinical investigation 99 (4), 618-627, 1997 | 267 | 1997 |
| Stat5 promotes homotypic adhesion and inhibits invasive characteristics of human breast cancer cells AS Sultan, J Xie, MJ LeBaron, EL Ealley, MT Nevalainen, H Rui Oncogene 24 (5), 746-760, 2005 | 236 | 2005 |
| Activation of signal transducer and activator of transcription 5 in human prostate cancer is associated with high histological grade H Li, TJ Ahonen, K Alanen, J Xie, MJ LeBaron, TG Pretlow, EL Ealley, ... Cancer research 64 (14), 4774-4782, 2004 | 218 | 2004 |
| Increased expression of cyclooxygenase-2 and nitric oxide synthase-2 in human prostate cancer P Uotila, E Valve, P Martikainen, M Nevalainen, M Nurmi, P Härkönen Urological research 29, 25-28, 2001 | 209 | 2001 |
| Inhibition of transcription factor Stat5 induces cell death of human prostate cancer cells TJ Ahonen, J Xie, MJ LeBaron, J Zhu, M Nurmi, K Alanen, H Rui, ... Journal of Biological Chemistry 278 (29), 27287-27292, 2003 | 176 | 2003 |
| Autocrine prolactin promotes prostate cancer cell growth via Janus kinase-2-signal transducer and activator of transcription-5a/b signaling pathway A Dagvadorj, S Collins, JB Jomain, J Abdulghani, J Karras, T Zellweger, ... Endocrinology 148 (7), 3089-3101, 2007 | 174 | 2007 |
| Stat5 promotes metastatic behavior of human prostate cancer cells in vitro and in vivo L Gu, P Vogiatzi, M Puhr, A Dagvadorj, J Lutz, A Ryder, S Addya, ... Endocrine-related cancer 17 (2), 481, 2010 | 165 | 2010 |
| Exosome-mediated transfer of αvβ3 integrin from tumorigenic to nontumorigenic cells promotes a migratory phenotype A Singh, C Fedele, H Lu, MT Nevalainen, JH Keen, LR Languino Molecular cancer research 14 (11), 1136-1146, 2016 | 155 | 2016 |
| Signal transducer and activator of transcription 5A/B in prostate and breast cancers SH Tan, MT Nevalainen Endocrine-related cancer 15 (2), 367-390, 2008 | 155 | 2008 |
| Activation of signal transducer and activator of transcription-5 in prostate cancer predicts early recurrence H Li, Y Zhang, A Glass, T Zellweger, E Gehan, L Bubendorf, EP Gelmann, ... Clinical Cancer Research 11 (16), 5863-5868, 2005 | 151 | 2005 |
| miR-375 induces docetaxel resistance in prostate cancer by targeting SEC23A and YAP1 Y Wang, R Lieberman, J Pan, Q Zhang, M Du, P Zhang, M Nevalainen, ... Molecular cancer 15, 1-11, 2016 | 146 | 2016 |
| Androgen receptor-dependent and-independent mechanisms driving prostate cancer progression: Opportunities for therapeutic targeting from multiple angles DT Hoang, KA Iczkowski, D Kilari, W See, MT Nevalainen Oncotarget 8 (2), 3724, 2016 | 142 | 2016 |
| Expression and hormone regulation of prolactin receptors in rat dorsal and lateral prostate MT Nevalainen, EM Valve, PM Ingleton, PL Härkönen Endocrinology 137 (7), 3078-3088, 1996 | 133 | 1996 |
| Transcription factor Stat5 synergizes with androgen receptor in prostate cancer cells SH Tan, A Dagvadorj, F Shen, L Gu, Z Liao, J Abdulghani, Y Zhang, ... Cancer research 68 (1), 236-248, 2008 | 132 | 2008 |
| Transcription Factor Signal Transducer and Activator of Transcription 5 Promotes Growth of Human Prostate Cancer Cells In vivo A Dagvadorj, RA Kirken, B Leiby, J Karras, MT Nevalainen Clinical Cancer Research 14 (5), 1317-1324, 2008 | 122 | 2008 |
| Prolactin is a survival factor for androgen-deprived rat dorsal and lateral prostate epithelium in organ culture TJ Ahonen, PL Härkönen, J Laine, H Rui, PM Martikainen, ... Endocrinology 140 (11), 5412-5421, 1999 | 121 | 1999 |
| Loss of nuclear localized and tyrosine phosphorylated Stat5 in breast cancer predicts poor clinical outcome and increased risk of antiestrogen therapy failure AR Peck, AK Witkiewicz, C Liu, GA Stringer, AC Klimowicz, E Pequignot, ... Journal of Clinical Oncology 29 (18), 2448-2458, 2011 | 119 | 2011 |
